Borrow P, Lewicki H, Wei X, Horwitz M S, Peffer N, Meyers H, Nelson J A, Gairin J E, Hahn B H, Oldstone M B, Shaw G M
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037, USA.
Nat Med. 1997 Feb;3(2):205-11. doi: 10.1038/nm0297-205.
The HIV-1-specific cytotoxic T lymphocyte (CTL) response is temporally associated with the decline in viremia during primary HIV-1 infection, but definitive evidence that it is of importance in virus containment has been lacking. Here we show that in a patient whose early CTL response was focused on a highly immunodominant epitope in gp 160, there was rapid elimination of the transmitted virus strain and selection for a virus population bearing amino acid changes at a single residue within this epitope, which conferred escape from recognition by epitope-specific CTL. The magnitude (> 100-fold), kinetics (30-72 days from onset of symptoms) and genetic pathways of virus escape from CTL pressure were comparable to virus escape from antiretroviral therapy, indicating the biological significance of the CTL response in vivo. One aim of HIV-1 vaccines should thus be to elicit strong CTL responses against multiple codominant viral epitopes.
HIV-1特异性细胞毒性T淋巴细胞(CTL)反应在时间上与原发性HIV-1感染期间病毒血症的下降相关,但一直缺乏确凿证据表明其在控制病毒方面具有重要性。在此,我们展示了在一名早期CTL反应集中于gp160中一个高度免疫显性表位的患者中,传播的病毒株被快速清除,并选择出了在该表位内单个残基处带有氨基酸变化的病毒群体,这使得该病毒群体能够逃避表位特异性CTL的识别。病毒从CTL压力下逃逸的幅度(>100倍)、动力学(症状出现后30 - 72天)和遗传途径与从抗逆转录病毒治疗中逃逸的情况相当,这表明CTL反应在体内具有生物学意义。因此,HIV-1疫苗的一个目标应该是引发针对多个共显性病毒表位的强烈CTL反应。